ArticlePloS one2023
Graphene surface plasmon sensor for ultra-low-level SARS-CoV-2 detection.
Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 19 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Precisely detecting the ultra-low-level severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial. The detection mechanism must be sensitive, low-cost, portable, fast, and easy to operate to tackle coronavirus disease 19 (COVID-19). This work proposes a sensor exploiting graphene surface plasmon resonance to detect SARS-CoV-2. The graphene layer functionalized with angiotensin-converting enzyme 2 (ACE2) antibodies will help efficient adsorption of the SARS-CoV-2. In addition to the graphene layer, ultra-thin layers of novel two-dimensional materials tungsten disulfide (WS2), potassium niobate (KNbO3), and black phosphorus (BP) or blue phosphorus (BlueP) used in the proposed sensor will increase the light absorption to detect an ultra-low SARS-CoV-2 concentration. The analysis presented in this work shows that the proposed sensor will detect SARS-CoV-2 as small as ∼1 fM. The proposed sensor also offers a minimum sensitivity of 201 degrees/RIU, a figure-of-merit of 140 RIU-1, and enhanced binding kinetics of the SARS-CoV-2 to the sensor surface.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.